Intravitreal Aflibercept Injection 2mg
VGFTe-AMD-1819
Approved small_molecule active
Quick answer
Intravitreal Aflibercept Injection 2mg for Neovascular Age-related Macular Degeneration is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Neovascular Age-related Macular Degeneration
- Phase
- Approved
- Modality
- small_molecule
- Status
- active